Boston – May 20, 2021 – Amy Baker Mandragouras has joined Cooley as a Boston-based partner in its leading life sciences patent counseling & prosecution practice, continuing the firm’s notable East Coast expansion. Arriving from Nelson Mullins, where she was a leader of the life sciences patent practice, Mandragouras brings 30 years of experience providing strategic IP advice and counseling to the biotechnology and pharmaceutical industries. Accompanying Mandragouras into Cooley’s strategically growing life sciences practice is a team of experienced patent lawyers and PhD technical specialists.
“Amy is a well-known and respected practitioner across the Boston legal market, and her arrival will prove instrumental in strengthening our life sciences-focused patent work in the Northeast and across the globe,” said Ivor Elrifi, chair of Cooley's global patent counseling & prosecution practice group. “We are excited to add her depth and experience to our team, as more and more game-changing life sciences companies continue to call Boston home.”
Mandragouras and her team focus on helping clients develop and implement effective IP strategies and build strong patent portfolios to protect new products and facilitate commercialization of biopharmaceuticals. She has extensive experience advising on the patent and IP aspects of biotechnology and pharmaceutical collaborations, acquisitions, licensing, financing transactions and securities offerings. Mandragouras’ clients range from startups to leading companies, including some of the most well-known names in the life sciences industry.
“I am impressed with the breadth of Cooley’s life sciences platform and excited to become part of its outstanding patent counseling & prosecution group, providing clients with the experience and insight they need to drive innovation in the thriving Boston life sciences market,” said Mandragouras. “I’ve enjoyed collaborating closely with Cooley partner Heidi Erlacher for clients over many years and am thrilled to combine my team with such a talented life sciences IP group.”
Mandragouras, who earned her JD from Northeastern University School of Law, has been named a Life Sciences Star by LMG, as well as an IP Star and one of the Top 250 Women in IP by Managing Intellectual Property, among other accolades. She spent nearly 20 years at Lahive & Cockfield, becoming the first woman chair of its executive committee. In this role, Mandragouras led negotiations and was a key figure in its combination with Nelson Mullins in 2010. During her time at Nelson Mullins, she served in several leadership roles, including as managing partner of its Boston office and chair of the Boston office’s diversity, equity and inclusion committee. Throughout her career, Mandragouras has championed gender diversity in patent law through proactive hiring, training and mentoring of women, and she will continue to do so with colleagues at Cooley.
Cooley has one of the largest dedicated life sciences and medical device patent teams of any law firm in the US. The firm’s extraordinarily deep and experienced bench of life sciences patent lawyers and technical professionals partner with game-changing innovators and their investors to align patent strategy with business strategy. For more than 40 years, Cooley has been at the forefront in working alongside leading life sciences companies across the globe. The firm is counsel to 1,400+ public and private life sciences companies worldwide, including more than 50% of the companies on the Nasdaq Biotechnology Index.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 1,200 lawyers across 17 offices in the United States, Asia and Europe.